4种评分系统对HBV相关慢加急性肝衰竭合并食管胃底静脉曲张出血患者短期预后的评估价值

肝脏 ›› 2022, Vol. 27 ›› Issue (4): 421-425.

4种评分系统对HBV相关慢加急性肝衰竭合并食管胃底静脉曲张出血患者短期预后的评估价值

王爱民, 梅雪, 郭红英, 袁伟, 张宇一, 钱志平, 王介非, 刘玉

201318 上海市监狱总医院(王爱民);上海市(复旦大学附属)公共卫生临床中心(梅雪,郭红英,袁伟,张宇一,钱志平,王介非,刘玉)

收稿日期:2021-12-27 出版日期:2022-04-30 发布日期:2022-06-02
通讯作者: 刘玉,Email:liuyu@shphc.org.cn
基金资助:
申康三年行动计划重大临床研究项目(SHDC2020CR1037B-004);国家自然科学面上项目基金(81874436);国家“十三五”科技重大专项(2018ZX10725506-002)

Clinical value of 4 scoring systems in evaluating the short-term prognosis of patients suffering from HBV-ACLF complicated with esophageal gastric variceal bleeding

WANG Ai-min², MEI Xue¹, GUO Hong-ying¹ , YUAN Wei¹, ZHANG Yu-yi¹, QIAN Zhi-ping¹, WANG Jie-fei¹, LIU Yu¹

1. Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China;
2. Department of Infectious diseases, General Hospital of Shanghai Prison, Shanghai 201318, China

Received:2021-12-27 Online:2022-04-30 Published:2022-06-02
Contact: LIU Yu,Email:liuyu@shphc.org.cn

摘要/Abstract

摘要： 目的探讨LSPS、ALBI、MELD及CTP评分系统对HBV相关慢加急性肝衰竭合并食管胃底静脉曲张出血患者短期预后的应用价值。方法纳入2018年12月18日至2021年9月6日上海市公共卫生临床中心收治的HBV相关慢加急性肝衰竭合并食管胃底静脉曲张出血患者52例。根据28 d预后情况分为存活组35例和死亡组17例,观察对比两组患者的临床资料并计算评分,使用ROC曲线评估4个评分系统对纳入患者28 d和90 d死亡的预测效能。结果死亡组和存活组比较,TBil[395.6(97.9,562.9)比211.9(41.7,422.6)μmol/L]、门静脉内径[13(12.5,14)比12(10,13)mm]、脾直径[13.2(11.9,16.1)比11.8(11,12.05)cm]明显偏高(均P<0.05),肝性脑病(94.1%比11.4%)、肝肾综合征(100.0%比57.1%)、感染(100.0%比65.7%)发生率明显偏高(均P<0.05),ALBI[-2.3(-2.69,-1.87)比-2.7(-3.01,-2.37)]、MELD[18.94(11.8,38.6)比12.47(4.64,22.58)]及CTP[14(13,14)比11(9,12)]评分明显偏高(均P<0.05)。28 d死亡风险的ROC曲线分析显示LSPS、ALBI、MELD及CTP评分的AUC分别为0.533、0.620、0.664、0.848,CTP评分预测28 d病死率效能最好(P<0.05);90 d死亡风险的ROC曲线分析显示,LSPS、ALBI、MELD及CTP评分的AUC分别为0.633、0.586、0.656、0.805,CTP评分预测90 d病死率效能较高(P<0.05)。结论 CTP评分预测HBV-ACLF并发EGVB患者短期预后效能显著。

Abstract: Objective To investigate the clinical value of liver stiffness-spleen diameter-to-platelet ratio score (LSPS), albumin-bilirubin scoring model (ALBI), model for end-stage liver disease (MELD) and Child-Turcotte-Pugh (CTP) in evaluating short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and esophagealgastric variceal bleeding (EGVB).Methods Fifty-two patients with HBV-ACLF and EGVB admitted to our hospital from December 18, 2018 to September 6, 2021 were collected. According to 28-day prognosis, they were divided into survival group (35 cases) and death group (17 cases). The clinical data of patients were analyzed and the scores of the 4 scoring systems were calculated. The efficacy of the 4 scoring systems in predicting the 28-day and 90-day mortality was evaluated by receiver operating characteristic (ROC) curve.Results Compared with survival group, patients in death group had higher total bilirubin (TBIL) level [395.6(97.9, 562.9) vs 211.9(41.7, 422.6) umol/L], portal vein diameter [13(12.5, 14) vs 12(10, 13) mm] and spleen diameter [13.2(11.9, 16.1) vs 11.8(11, 12.05) cm]. The incidence rates of hepatic encephalopathy (94.1% vs 11.4%), hepatorenal syndrome (100.0% vs 57.1%) and infections (100.0% vs 65.7%) (P<0.05) in the death group were significantly higher. The scores of ALBI [-2.3(-2.69, -1.87) vs (-2.7(-3.01, -2.37))], MELD [18.94(11.8, 38.6) vs 12.47(4.64, 22.58)] and CTP [14(13, 14.5) vs 11(9, 12)] of death group were significantly also higher. ROC curve analysis of the 28-day death risk showed that the area under the curve (AUC) of LSPS, ALBI, MELD and CTP scores were 0.533, 0.620, 0.664 and 0.848, suggesting the CTP scoring system was superior to the other three ( P<0.05) in predicting the 28-day mortality. ROC curve analysis of the 90-day death risk showed that the AUC of LSPS, ALBI, MELD and CTP scores were 0.633, 0.586, 0.656 and 0.805, suggesting the CTP scoring system performed better in predicting the 90-day mortality ( P<0.05).Conclusion CTP scoring system performs better in predicting the short-term prognosis of patients with HBV-ACLF and EGVB.

Key words: Hepatitis B virus-related acute on chronic liver failure, Esophageal and gastric variceal bleeding, Child-Turcotte-Pugh score, Short-term prognosis

王爱民, 梅雪, 郭红英, 袁伟, 张宇一, 钱志平, 王介非, 刘玉. 4种评分系统对HBV相关慢加急性肝衰竭合并食管胃底静脉曲张出血患者短期预后的评估价值[J]. 肝脏, 2022, 27(4): 421-425.

WANG Ai-min, MEI Xue, GUO Hong-ying , YUAN Wei, ZHANG Yu-yi, QIAN Zhi-ping, WANG Jie-fei, LIU Yu. Clinical value of 4 scoring systems in evaluating the short-term prognosis of patients suffering from HBV-ACLF complicated with esophageal gastric variceal bleeding[J]. Chinese Hepatolgy, 2022, 27(4): 421-425.

参考文献

[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版).临床肝胆病杂志,2019,35:38-44.
[2] Manatsathit W,Samant H,Kapur S,et al. Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score in detection of esophageal varices: Systemic review and meta-analysis. J Gastroenterol Hepatol,2018,33:1696-1706.
[3] Johnson PJ,Berhane S,Kagebayashi C,et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach the ALBI grade. J Clin Oncol,2015,33:550-558.
[4] Kamath PS,Wiesner RH,Malinchoc M,et al. A model to predict survival in patients with end-stage liver disease. Hepatology,2001,33:464-470.
[5] Fortune BE,Garcia-Tsao G,Ciarleglio M,et al. Child-Turcotte-Pugh class is best at stratifying risk in variceal hemorrhage: analysis of a US multicenter prospective study. J Clin Gastroenterol,2017,51:446-453.
[6] Hernaez R,Kramer JR,Liu Y,et al. Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA. J Hepatol,2019,70:639-647.
[7] Flamm SL,Yang YX,Singh S,et al. AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guidelines for the Diagnosis and Management of Acute Liver Failure. Gastroenterology,2017,152:644-647.
[8] Guo HY,Zhang ZG,Zhang YY,et al. Risks and predicting factors of bleeding complications in hepatitis B virus-related acute-on-chronic liver failure. Turk J Gastroenterol,2020,31:620-625.
[9] 代琴棋,周延,陆钊,等. 慢加急性肝衰竭患者并发上消化道出血的危险因素分析. 国际流行病学传染病学杂志,2020,2:162-165.
[10] Shibata S,Joshita S,Umemura T,et al. Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.Springerplus,2016,5:998.
[11] Malek MS,Hoque MN,Azam MG,et al. Prediction of esophageal varices in chronic liver disease by liver stiffness-spleen size-to-plalelet ratio risk score. Mymensingh Med J,2021,30:115-122.
[12] Wang J,Zhang Z, Yan X,et al. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.Dig Liver Dis,2019,51:1172-1178.
[13] Hsieh YC, Lee KC, Wang YW,et al. Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score. PLoS One,2018,13:e0208903.
[14] Liu LX,Zhang Y,Nie Y,et al. Assessing the prediction effect of various prognosis model for 28-day mortality in acute-on-chronic liver failure patients. Risk ManagHealthc Policy,2020,13:3155-3163.
[15] Li H,Zheng J, Chen L,et al. The scoring systems in predicting short-term outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. Ann Palliat Med,2020,9:3048-3058.
[16] Lei Q,Zhang Y,Ke C,et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma. Exp Ther Med,2018,15:3074-3079.
[17] Xavier SA,Vilas-Boas R,Boal Carvalho P,et al. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol,2018,30:652-658.
[18] Zou D,Qi X,Zhu C,et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Turk J Gastroenterol,2016,27:180-186.
[19] Voicu MN,Popescu F,Florescu DN,et al. Clostridioides difficile Infection among cirrhotic patients with variceal bleeding. Antibiotics (Basel),2021,10:731.
[20] Yang L,Sun R,Wei N,et al. Systematic review and meta-analysis of risk scores in prediction for the clinical outcomes in patients with acute variceal bleeding. Ann Med,2021,53:1806-1815.
[21] Kumar M,Kainth S,Choudhury A,et al. Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial.Hepatol Int,2019,13:800-813.

编辑推荐 0

Metrics

阅读次数

全文

230

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	230

来源	本网站	其他网站

次数	221	9
比例	96%	4%

摘要

202

最新录用	在线预览	正式出版

0	0	202

	来源	本网站

	次数	202
	比例	100%